AIM ImmunoTech Inc [AIM] stock prices are up 4.73% to $2.88 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AIM shares have gain 10.34% over the last week, with a monthly amount glided 11.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of AIM ImmunoTech Inc [AIM] has been fluctuating between $2.33 and $36.00 over the past year. AIM ImmunoTech Inc [AMEX: AIM] shares were valued at $2.88 at the most recent close of the market.
Analyzing the AIM fundamentals
The AIM ImmunoTech Inc [AMEX:AIM] reported sales of 0.12M for trailing twelve months, representing a drop of -50.00%. Gross Profit Margin for this corporation currently stands at 1.19% with Operating Profit Margin at -137.26%, Pretax Profit Margin comes in at -133.6%, and Net Profit Margin reading is -133.6%. To continue investigating profitability, this company’s Return on Assets is posted at -3.92, Equity is 7.34 and Total Capital is 2.65. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.43.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.56 points at the first support level, and at 2.24 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.07, and for the 2nd resistance point, it is at 3.26.
Ratios To Look Out For
It’s worth pointing out that AIM ImmunoTech Inc [AMEX:AIM]’s Current Ratio is 0.10. Also, the Quick Ratio is 0.10, while the Cash Ratio stands at 0.05. Considering the valuation of this stock, the price to sales ratio is 65.02.
Transactions by insiders
Recent insider trading involved Equels Thomas K, CEO & President, that happened on Apr 04 ’25 when 41000.0 shares were purchased. COO, Secretary, Gen. Counsel, Rodino Peter W III completed a deal on Apr 04 ’25 to buy 500.0 shares. Meanwhile, CEO & President Equels Thomas K bought 50000.0 shares on Mar 05 ’25.
